Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Schneider, Lon S.
Martinez, Rick A.
and
Lebowitz, Barry D.
1993.
Clinical psychopharmacology research in geriatrics: An agenda for research.
International Journal of Geriatric Psychiatry,
Vol. 8,
Issue. 1,
p.
89.
Marin, Deborah B.
Bierer, Linda M.
Lawlor, Brian A.
Ryan, Theresa M.
Jacobson, Rachel
Schmeidler, James
Mohs, Richard C.
and
Davis, Kenneth L.
1995.
l-Deprenyl and physostigmine for the treatment of Alzheimer's disease.
Psychiatry Research,
Vol. 58,
Issue. 3,
p.
181.
Little, J. T.
Broocks, A.
Martin, A.
Hill, J. L.
Tune, L. E.
Mack, C.
Cantillon, M.
Molchan, S.
Murphy, D. L.
and
Sunderland, T.
1995.
Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans.
Psychopharmacology,
Vol. 120,
Issue. 3,
p.
280.
Wilcock, G. K.
and
Harrold, P. L.
1996.
Treatment of Alzheimer's disease: future directions.
Acta Neurologica Scandinavica,
Vol. 94,
Issue. S165,
p.
128.
Shihabuddin, Lina
and
Davis, Kenneth
1996.
Alzheimer's Disease.
Fink, David M.
Palermo, M.G.
Bores, Gina M.
Huger, Francis P.
Kurys, Barbara E.
Merriman, Michael C.
Olsen, Gordon E.
Petko, Wayne
and
O'Malley, Gerard J.
1996.
Imino 1,2,3,4-tetrahydrocyclopent[b]indole carbamates as dual inhibitors of acetylcholinesterase and monoamine oxidase.
Bioorganic & Medicinal Chemistry Letters,
Vol. 6,
Issue. 6,
p.
625.
Tolbert, Sandra R.
and
Fuller, Matthew A.
1996.
Selegiline in Treatment of Behavioral and Cognitive Symptoms of Alzheimer Disease.
Annals of Pharmacotherapy,
Vol. 30,
Issue. 10,
p.
1122.
Doraiswamy, P. Murali
and
Steffens, David C.
1998.
Combination Therapy for Early Alzheimer's Disease: What Are We Waiting for?.
Journal of the American Geriatrics Society,
Vol. 46,
Issue. 10,
p.
1322.
Tariot, Pierre N.
Goldstein, Bonnie
Podgorski, Carol Ann
Cox, Christopher
and
Frambes, Nancy
1998.
Short-Term Administration of Selegiline for Mild-to-Moderate Dementia of the Alzheimer's Type.
The American Journal of Geriatric Psychiatry,
Vol. 6,
Issue. 2,
p.
145.
Möller, Hans-Jürgen
1999.
Reappraising neurotransmitter-based strategies.
European Neuropsychopharmacology,
Vol. 9,
Issue. ,
p.
S53.
Coelho Filho, João M JMC
and
Birks, Jacqueline
2001.
Physostigmine for dementia due to Alzheimer's disease.
Cochrane Database of Systematic Reviews,
Wilcock, G. K.
Birks, J.
Whitehead, A.
and
Evans, Sir John Grimley
2002.
The effect of selegiline in the treatment of people with Alzheimer's disease: a meta‐analysis of published trials.
International Journal of Geriatric Psychiatry,
Vol. 17,
Issue. 2,
p.
175.
Lawlor, Brian A.
Swanwick, Gregory
Carrier, Louise
and
Tariot, Pierre
2003.
Evidence‐based Dementia Practice.
p.
675.
Birks, Jacqueline
and
Flicker, Leon
2003.
Selegiline for Alzheimer's disease.
Cochrane Database of Systematic Reviews,